Dogs refractory to compound 48/80 and sinomenine by Endo, Koiti & Yamasaki, Hidemasa
Acta Medica Okayama
Volume 23, Issue 6 1969 Article 11
DECEMBER 1969
Dogs refractory to compound 48/80 and
sinomenine
Koiti Endo∗ Hidemasa Yamasaki†
∗Okayama University,
†Okayama University,
Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.
Dogs refractory to compound 48/80 and
sinomenine∗
Koiti Endo and Hidemasa Yamasaki
Abstract
Five (21 per cent) out of 24 mongrel dogs were found to be refractory to compound 48/80
and also to sinomenine (cross-tolerance). These nonreactor dogs responded normally to PVP and
tween 20 and showed normal sensitivity to histamine. The incidence was similar in both sexes.
Mechanisms of this type refractoriness were discussed.
∗PMID: 4192963 [PubMed - indexed for MEDLINE] Copyright c©OKAYAMA UNIVERSITY
MEDICAL SCHOOL
Acta Med. Okayama 23, 589-592 (1969)
DOGS REFRACTORY TO COMPOUND 48j80 AND
SINOMENINE
Koiti ENDO and Hidemasa YAMASAKI
Department of Pharmacology, Okayama University Medical School, Okayama, Japan
(Director: Prof. H. Yamasaki)
Received for publication, July 14, 1969
WEST and HARRIS (1, 2) secured rats, from one Wistar albino colony,
resistant to the first injection of dextran or egg-white, failing to develop
the so-called anaphylactoid reactions, and they showed further that this
nonreactivity was an autosomal recessive character. But we have yet
no information concerning naturally or congenitally resistant individuals
to histamine liberators or histamine-releasing agents in other species of
animal. Fifteen years ago, MAYEDA (3) working in this laboratory on
the histamine-releasing properties of a plant alkaloid, sinomenine, found
unexpectedly that 11 (14 per cent) out of 78 dogs were refractory to the
depressor action of this histamine liberator. We again noticed, during the
course of recent work, that some dogs were nonreactive to the hypotensive
actions of both compound 48 j80 and sinomenine, that is, they were cross-
tolerant to either liberator. This brief account concerns with experiences
on these nonreactor dogs.
Observations were made on 24 mongrel dogs in either sex (13 males
and 11 females), whose carotid blood pressures were recorded on a smoked
drum by means of mercury manometer under anesthesia by intravenous
injection of pentobarbital sodium 35 mgjkg. Eighteen dogs (9 males and
9 females) weighing 7.5 to 18.5 kg were injected 0.7 to 1.0 mg/kg doses
of compound 48/80 intravenously. Fifteen dogs among them showed a
typical reaction of rapid and profound fall of the arterial pressure, reaching
the maximal fall of 71 to 84 per cent, except one who died from a severe
shock by 0.7 mg/kg of 48/80 about 5 minutes after the injection. But, to
our interest, other 3 dogs (one male, 9.2 kg; 2 females, 12 and 13.5 kg)
were completely refractory to the first injection of mentioned doses of
48/80, and these dogs were also unresponsive to the following injection
of 3 mg/kg, a shock dose, of sinomenine hydrochloride (Fig. 1).
Another group of 6 dogs (4 males and 2 females), weighing 5.5 to
12.6 kg, were received the first intravenous injection of 3 mg/kg of sino-
menine hydrochloride. Among them 4 dogs reacted normally with a steep
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Fig. 1. Carotid blood pressure of a dog refractory to compound 48/80 and sinome-
nine. A marked hypotension was produced by a subsequent intravenous injection of tween
20, although after this a shock dose of PVP was no longer effective probably being due
to exhaution of releasable histamine stores. Normal sensitivity to histamine is shown. Dog,
13.5 kg female.
and marked hypotension, showing the maximal fall ranging from 68 to
91 per cent, but remaining 2 dogs (both males, 9.8 and 10.5 kg) were not
only entirely refractory to the sinomenine injection, but also failed to show
any depressor reaction to 1.0 mg/kg of compound 48/80 injected about
10 minutes later.
Dogs who had been proved to be refractory to 48/80 and sinomenine
were injected intravenously either polyvinylpyrrolidone (PVP) 500 mg/kg
or tween 20 30 mg/kg. These nonreactor dogs now reacted normally to
either histamine-releasing agent, showing a marked hypotension, although
after the recovery renewed injections of both PVP and tween were no
longer effective. Histamine was as active as in control dogs (Fig. 1).
. It will be seen that the percentage of nonreactor dogs (21 per cent, 5
out of 24) was similar in both sexes (male 23 per cent, 3 out of 13; female
18 per cent, 2 out of 11) and did not vary from body weight to body weight
within the ranges in the present experiments.
An important element in the development of refractoriness to hista.
mine release is the exhaution of the releasable histamine stores. But, this is
the cause improbable in the present refractoriness to 48/80 or sinomenine,
since the nonreactor dogs responded with conspicuous hypotensions to PVP
or tween 20 which are both known histamine.releasing agent specific to this
animal. SLOMKA and GOTH (4) succeeded in dogs to produce a refractory
state to compound 48/80 by injecting a series of graded doses of this com·
pound, and they considered this refractory state to be effected by a mean
other than depletion of available histamine stores. KOMOTO and YAMASAKI
(5) confirmed this finding, and further successfully secured sinomenine-
resistant dogs by a similar technique, repeating injections of a series of
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increasing doses starting with a very small dose of sinomenine. They found
that these dogs were also endowed with the refractoriness to the hypoten-
sive effect of compound 48/80. Since no increase in plasma histamine was
seen after each injection during the treatment and also the histamine
content in the skin remained unchanged after the refractoriness was estab-
lished, this refractoriness might not be the result of exhaution of the
releasable histamine in the body stores. RILEY and WEST (6, 7) have made
the interesting observation that with long-continued administration of
compound 48/80, the reduced histamine content of rat subcutaneous tissue
begins to rise again slowly, accompanied by the appearance of small dense
new mast cells in close relation to the blood vessels, cells which now resist
degranulation by 48/80. All these observations seem to make it possible
that mast cells can be made resistant to certain types of histamine liberator.
What is the mechanism by which this can be achieved? There are
two possibilities that can be considered: one is the lack or masking of the
receptors for the histamine liberators postulated in the surface membranes
of mast cell; another is the deficient or inability of the element(s) neces-
sary to the enzymatic processes involved in the histamine release mechanisms
in mast cells~ Recent observation (8) that toluidine blue disrupts mast cells
before entering into the cytoplasmic milieu seems favorable for the receptor
concept. This receptor theory also favorably permits explanation of the
cross-tolerance for compound 48/80 and sinomenine since these compounds
are chemically simple bases and of close similarity in their modes of action
on mast cells (9, 10). Whether the present refractoriness is naturally
acquired or hereditarily controllable, should also be a matter of interest
to be followed.
SUMMARY
Five (21 per cent) out of 24 mongrel dogs were found to be refractory
to compound 48/80 and also to sinomenine (cross-tolerance). These non-
reactor dogs responded normally to PVP and tween 20 and showed normal
sensitivity to histamine. The incidence was similar in both sexes. Mecha-
nisms of this type refractoriness were discussed.
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